Literature DB >> 22249460

Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.

Nichola Zoe Lax1, Philippa Denis Hepplewhite, Amy Katherine Reeve, Victoria Nesbitt, Robert McFarland, Evelyn Jaros, Robert William Taylor, Douglass Matthew Turnbull.   

Abstract

Cerebellar ataxia is a prominent clinical symptom in patients with mitochondrial DNA (mtDNA) disease. This is often progressive with onset in young adulthood. We performed a detailed neuropathologic investigation of the olivary-cerebellum in 14 genetically and clinically well-defined patients with mtDNA disease. Quantitative neuropathologic investigation showed varying levels of loss of Purkinje cells and neurons of the dentate nucleus and inferior olivary nuclei. Typically, focal Purkinje cell loss was present in patients with the m.3243A>G mutation caused by the presence of microinfarcts, with relative preservation of neuronal cell populations in the olivary and dentate nuclei. In contrast, patients with the m.8344A>G mutation or recessive POLG mutations showed extensive and global neuronal cell loss in all 3 olivary-cerebellum areas examined. Molecular analysis of mutated mtDNA heteroplasmy levels revealed that neuronal cell loss occurred independently of the level of mutated mtDNA present within surviving neurons. High levels of neuronal respiratory chain deficiency, particularly of complex I, were detected in surviving cells; levels of deficiency were greater in regions with extensive cell loss. We found a relationship between respiratory deficiency and neuronal cell density, indicating that neuronal cell death correlates with respiratory deficiency. These findings highlight the vulnerability of the olivary-cerebellum to mtDNA defects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249460      PMCID: PMC3272439          DOI: 10.1097/NEN.0b013e318244477d

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  47 in total

1.  Mitochondrial encephalomyopathy with lactic acidosis and stroke like episodes (MELAS) with prominent degeneration of the intestinal wall and cactus-like cerebellar pathology.

Authors:  O Mori; M Yamazaki; Y Ohaki; Y Arai; T Oguro; H Shimizu; G Asano
Journal:  Acta Neuropathol       Date:  2000-12       Impact factor: 17.088

2.  Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.

Authors:  J Betts; E Jaros; R H Perry; A M Schaefer; R W Taylor; Z Abdel-All; R N Lightowlers; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2006-08       Impact factor: 8.090

3.  Cerebellar ataxia in patients with Leber's hereditary optic neuropathy.

Authors:  I Funakawa; H Kato; A Terao; K Ichihashi; S Kawashima; T Hayashi; K Mitani; S Miyazaki
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

4.  Atrophy of the cerebellar vermis in ageing. A morphometric and histologic study.

Authors:  A Torvik; S Torp; C F Lindboe
Journal:  J Neurol Sci       Date:  1986-12       Impact factor: 3.181

5.  Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion.

Authors:  Anna H Hakonen; Steffi Goffart; Sanna Marjavaara; Anders Paetau; Helen Cooper; Kimmo Mattila; Milla Lampinen; Antti Sajantila; Tuula Lönnqvist; Johannes N Spelbrink; Anu Suomalainen
Journal:  Hum Mol Genet       Date:  2008-09-05       Impact factor: 6.150

6.  MR of the brain in mitochondrial myopathy.

Authors:  S H Wray; J M Provenzale; D R Johns; K R Thulborn
Journal:  AJNR Am J Neuroradiol       Date:  1995-05       Impact factor: 3.825

7.  Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Authors:  Nichola Z Lax; Graham R Campbell; Amy K Reeve; Nobuhiko Ohno; Jessica Zambonin; Emma L Blakely; Robert W Taylor; Eduardo Bonilla; Kurenai Tanji; Salvatore DiMauro; Evelyn Jaros; Hans Lassmann; Doug M Turnbull; Don J Mahad
Journal:  Arch Neurol       Date:  2012-04

Review 8.  A neurological perspective on mitochondrial disease.

Authors:  Robert McFarland; Robert W Taylor; Douglass M Turnbull
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

9.  Mitochondrial DNA mutations in human colonic crypt stem cells.

Authors:  Robert W Taylor; Martin J Barron; Gillian M Borthwick; Amy Gospel; Patrick F Chinnery; David C Samuels; Geoffrey A Taylor; Stefan M Plusa; Stephanie J Needham; Laura C Greaves; Thomas B L Kirkwood; Douglass M Turnbull
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

10.  Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells.

Authors:  D J Mahad; I Ziabreva; G Campbell; F Laulund; J L Murphy; A K Reeve; L Greaves; K J Smith; D M Turnbull
Journal:  J Neurosci Methods       Date:  2009-08-31       Impact factor: 2.390

View more
  42 in total

1.  p62/sequestosome-1 knockout delays neurodegeneration induced by Drp1 loss.

Authors:  Tatsuya Yamada; Yoshihiro Adachi; Toru Yanagawa; Miho Iijima; Hiromi Sesaki
Journal:  Neurochem Int       Date:  2017-05-18       Impact factor: 3.921

2.  Palatal Tremor in POLG-Associated Ataxia.

Authors:  Madhu Nagappa; Parayil Sankaran Bindu; Arun B Taly; Kothari Sonam; Chiplunkar Shwetha; Rakesh Kumar; Narayanappa Gayathri; M M Srinivas-Bharath; Hanumanthapura R Arvinda; Sanjib Sinha; Arumugam Paramasivam; Kumarasamy Thangaraj
Journal:  Mov Disord Clin Pract       Date:  2015-06-30

3.  Mitochondrial POLG related disorder presenting prenatally with fetal cerebellar growth arrest.

Authors:  Michal Inbar-Feigenberg; Susan Blaser; Cynthia Hawkins; Patrick Shannon; Stacy Hewson; David Chitayat
Journal:  Metab Brain Dis       Date:  2018-03-25       Impact factor: 3.584

4.  Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant.

Authors:  Siddharth Srivastava; Cynthia S Gubbels; Kira Dies; Anne Fulton; Timothy Yu; Mustafa Sahin
Journal:  J Child Neurol       Date:  2017-05-25       Impact factor: 1.987

5.  The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Authors:  Felix Chan; Nichola Z Lax; Caroline Marie Voss; Blanca Irene Aldana; Shuna Whyte; Alistair Jenkins; Claire Nicholson; Sophie Nichols; Elizabeth Tilley; Zoe Powell; Helle S Waagepetersen; Ceri H Davies; Doug M Turnbull; Mark O Cunningham
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

6.  Bilateral hypertrophic olivary nucleus degeneration on magnetic resonance imaging in children with Leigh and Leigh-like syndrome.

Authors:  P S Bindu; A B Taly; K Sonam; C Govindaraju; H R Arvinda; N Gayathri; M M Srinivas Bharath; D Ranjith; M Nagappa; S Sinha; N A Khan; K Thangaraj
Journal:  Br J Radiol       Date:  2014-02       Impact factor: 3.039

Review 7.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

8.  Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson's disease.

Authors:  Chun Chen; David McDonald; Alasdair Blain; Ashwin Sachdeva; Laura Bone; Anna L M Smith; Charlotte Warren; Sarah J Pickett; Gavin Hudson; Andrew Filby; Amy E Vincent; Doug M Turnbull; Amy K Reeve
Journal:  NPJ Parkinsons Dis       Date:  2021-05-12

9.  Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.

Authors:  Ilse S Pienaar; Joanna L Elson; Claudia Racca; Glyn Nelson; Douglass M Turnbull; Christopher M Morris
Journal:  Am J Pathol       Date:  2013-10-04       Impact factor: 4.307

10.  The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.

Authors:  Amy Reeve; Martin Meagher; Nichola Lax; Eve Simcox; Philippa Hepplewhite; Evelyn Jaros; Doug Turnbull
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.